Ken Griffin’s GenVec, Inc. GNVC Stock Holding History

Ken Griffin’s Portfolio GNVC Stock Details GNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,248	Closed	-$10K	–	8056
2016 Q1	$10K	Buy	+1,248	New	+$8.36K	﹤0.01%	6601
2015 Q3	–	Sell	-1,558	Closed	-$32K	–	9761
2015 Q2	$32K	Sell	1,558 -203	-12%	-$4.95K	﹤0.01%	7928
2015 Q1	$52K	Buy	+1,761	New	+$57.9K	﹤0.01%	7364
2013 Q4	–	Sell	-1,946	Closed	-$25K	–	7538
2013 Q3	$25K	Buy	+1,946	New	+$10.6K	﹤0.01%	6125

Other funds holding GNVC

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ken Griffin's GNVC Position: Q2 2016 in Review

Ken Griffin sold out of GenVec, Inc. (GNVC) in Q2 2016, closing a stake of 1,248 shares — an estimated $10K sold.

Ken Griffin first reported a position in GNVC in Q3 2013 and held it in 4 quarters. The position peaked at $52K in Q1 2015. 24 funds tracked by Wall St. Rank hold GNVC as of Q2 2016.

Ken Griffin reported no remaining GenVec, Inc. position as of Q2 2016 after selling out during the quarter.
Ken Griffin sold 1,248 GenVec, Inc. shares in Q2 2016, an estimated $10K.
Ken Griffin first reported a position in GenVec, Inc. in Q3 2013 and held it in 4 quarters.
Ken Griffin's GenVec, Inc. position peaked at $52K in Q1 2015.
24 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.